Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Clarification Request

RE: Your comment
"I spoke with Harry Lander shortly after the Kite deal was announced and he said Regen had the identical science but about a year behind and needed 25M to get to that point. Regen has since shelved that science in favour of the two mRNA IND's they have submitted which indicates how valuable they believe they are." i.e. the CAR-T cell therapy?

Q1. Are you saying that RGBP some time ago was working on developing CAR-T cell therapy but needed $25M they didn't have to advance that biotechnology, so they shelved that science in favor of two mRNA Cancer Vaccine INDs? If so, what year was it this happened?

Q2. The "Kite Deal that was announce?" What are you referring to? What deal was that, when, and with whom?

Thank you in advance for your response

Sincere regards